drugset / Trial / NCT06587698

Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

NCT06587698

Recruiting 300 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will be carried out under the guidance of professional doctor, patients with PCOS will be treated with Sitagliptin or BeiDouGen capsule or both two to assess their ovarian function and reproductive outcomes, and compare the effect of different treatment methods, which will provide the basis for PCOS intervention strategy and related research

Timeline

Start
2024-08-21
Primary completion
2028-07-01
Completion
2029-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject BeiDouGen Unknown 60 mg Oral
Subject Sitagliptin Small molecule 100 mg Oral